Filed NDA for the oral quinolone temafloxacin Nov. 30. Abbott is seeking a wide range of treatment indications, such as urinary tract and lower respiratory tract infections, including pneumonia and bronchitis; prostatitis; sexually transmitted diseases, including gonorrhea; and skin and skin structure infections.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."